<--- Back to Details
First PageDocument Content
Nephrogenic systemic fibrosis / Nephrology / Gadodiamide / Gadopentetic acid / Gadolinium / Magnetic resonance imaging / Gadobutrol / Gadobenic acid / Chronic kidney disease / Chemistry / Matter / Medicine
Nephrogenic systemic fibrosis
Nephrology
Gadodiamide
Gadopentetic acid
Gadolinium
Magnetic resonance imaging
Gadobutrol
Gadobenic acid
Chronic kidney disease
Chemistry
Matter
Medicine

Microsoft Word - MH Briefing Document -Final.doc

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 186,04 KB

Share Document on Facebook

Similar Documents

Insights into hypertension in children and adolescents in (South) Africa: the role of salt sensitivity Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

DocID: 1vj68 - View Document

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

DocID: 1uEgV - View Document

conferenceseries.com 9th International Conference on Nephrology: Kidney & Therapeutics September 29-30, 2016 Orlando, USA

DocID: 1uvE8 - View Document

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

DocID: 1uvxq - View Document

NRMP SMS Nephrology Match for Appointment Year 2016–2017: ASN Brief Analysis Kurtis Pivert, ASN Content and Media Analyst On December 2, 2015, the National Resident Matching Program (NRMP) released preliminary results

DocID: 1tmLJ - View Document